# Comparing the Prognosis of Lactate-directed and Goal-directed Therapy in Hyperthermic Intraperitoneal Chemotherapy.

> **NCT03933930** · NA · WITHDRAWN · sponsor: **Taipei Medical University WanFang Hospital**

## Conditions studied

- Organ Failure, Multiple

## Interventions

- **OTHER:** Lactate-directed therapy
- **OTHER:** Goal-directed therapy

## Key facts

- **NCT ID:** NCT03933930
- **Lead sponsor:** Taipei Medical University WanFang Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-05-06
- **Primary completion:** 2021-05-15
- **Final completion:** 2021-05-15
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No patient wants to be recruited.
- **Last updated:** 2020-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03933930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03933930, "Comparing the Prognosis of Lactate-directed and Goal-directed Therapy in Hyperthermic Intraperitoneal Chemotherapy.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03933930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*